The massively elevated serum levels of intact FGF23, as observed in late stages of chronic kidney disease (CKD) (57, 58), seem to result from an increase in FGF23 synthesis (59) accompanied by an inhibition of FGF23 cleavage (53, 60). This evidence concerns the gene FGF23 and chronic kidney disease.